268 related articles for article (PubMed ID: 26136428)
1. Galectin-3 Binding Protein Secreted by Breast Cancer Cells Inhibits Monocyte-Derived Fibrocyte Differentiation.
White MJ; Roife D; Gomer RH
J Immunol; 2015 Aug; 195(4):1858-67. PubMed ID: 26136428
[TBL] [Abstract][Full Text] [Related]
2. LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis.
Piccolo E; Tinari N; Semeraro D; Traini S; Fichera I; Cumashi A; La Sorda R; Spinella F; Bagnato A; Lattanzio R; D'Egidio M; Di Risio A; Stampolidis P; Piantelli M; Natoli C; Ullrich A; Iacobelli S
J Mol Med (Berl); 2013 Jan; 91(1):83-94. PubMed ID: 22864925
[TBL] [Abstract][Full Text] [Related]
3. Lectin galactoside-binding soluble 3 binding protein (LGALS3BP) is a tumor-associated immunomodulatory ligand for CD33-related Siglecs.
Läubli H; Alisson-Silva F; Stanczak MA; Siddiqui SS; Deng L; Verhagen A; Varki N; Varki A
J Biol Chem; 2014 Nov; 289(48):33481-91. PubMed ID: 25320078
[TBL] [Abstract][Full Text] [Related]
4. Identification of galectin-3-binding protein as a factor secreted by tumor cells that stimulates interleukin-6 expression in the bone marrow stroma.
Fukaya Y; Shimada H; Wang LC; Zandi E; DeClerck YA
J Biol Chem; 2008 Jul; 283(27):18573-81. PubMed ID: 18450743
[TBL] [Abstract][Full Text] [Related]
5. TNF-α-stimulated fibroblasts secrete lumican to promote fibrocyte differentiation.
Pilling D; Vakil V; Cox N; Gomer RH
Proc Natl Acad Sci U S A; 2015 Sep; 112(38):11929-34. PubMed ID: 26351669
[TBL] [Abstract][Full Text] [Related]
6. Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.
Bendre MS; Margulies AG; Walser B; Akel NS; Bhattacharrya S; Skinner RA; Swain F; Ramani V; Mohammad KS; Wessner LL; Martinez A; Guise TA; Chirgwin JM; Gaddy D; Suva LJ
Cancer Res; 2005 Dec; 65(23):11001-9. PubMed ID: 16322249
[TBL] [Abstract][Full Text] [Related]
7. Myosin IIa activation is crucial in breast cancer derived galectin-1 mediated tolerogenic dendritic cell differentiation.
Cheng DE; Hung JY; Huang MS; Hsu YL; Lu CY; Tsai EM; Hou MF; Kuo PL
Biochim Biophys Acta; 2014 Jun; 1840(6):1965-76. PubMed ID: 24468067
[TBL] [Abstract][Full Text] [Related]
8. Synthetic inhibitors of galectin-1 and -3 selectively modulate homotypic cell aggregation and tumor cell apoptosis.
Iurisci I; Cumashi A; Sherman AA; Tsvetkov YE; Tinari N; Piccolo E; D'Egidio M; Adamo V; Natoli C; Rabinovich GA; Iacobelli S; Nifantiev NE;
Anticancer Res; 2009 Jan; 29(1):403-10. PubMed ID: 19331179
[TBL] [Abstract][Full Text] [Related]
9. Trypsin, Tryptase, and Thrombin Polarize Macrophages towards a Pro-Fibrotic M2a Phenotype.
White MJ; Gomer RH
PLoS One; 2015; 10(9):e0138748. PubMed ID: 26407067
[TBL] [Abstract][Full Text] [Related]
10. A role for KMT1c in monocyte to dendritic cell differentiation: Epigenetic regulation of monocyte differentiation.
Wierda RJ; Goedhart M; van Eggermond MC; Muggen AF; Miggelbrink XM; Geutskens SB; van Zwet E; Haasnoot GW; van den Elsen PJ
Hum Immunol; 2015 Jun; 76(6):431-7. PubMed ID: 25843229
[TBL] [Abstract][Full Text] [Related]
11. Moraxella catarrhalis adhesin UspA1-derived recombinant fragment rD-7 induces monocyte differentiation to CD14+CD206+ phenotype.
Xie Q; Brackenbury LS; Hill DJ; Williams NA; Qu X; Virji M
PLoS One; 2014; 9(3):e90999. PubMed ID: 24599281
[TBL] [Abstract][Full Text] [Related]
12. Alterations in galectin-3 expression and distribution correlate with breast cancer progression: functional analysis of galectin-3 in breast epithelial-endothelial interactions.
Shekhar MP; Nangia-Makker P; Tait L; Miller F; Raz A
Am J Pathol; 2004 Dec; 165(6):1931-41. PubMed ID: 15579437
[TBL] [Abstract][Full Text] [Related]
13. Biological indicators of prognosis in Ewing's sarcoma: an emerging role for lectin galactoside-binding soluble 3 binding protein (LGALS3BP).
Zambelli D; Zuntini M; Nardi F; Manara MC; Serra M; Landuzzi L; Lollini PL; Ferrari S; Alberghini M; Llombart-Bosch A; Piccolo E; Iacobelli S; Picci P; Scotlandi K
Int J Cancer; 2010 Jan; 126(1):41-52. PubMed ID: 19544526
[TBL] [Abstract][Full Text] [Related]
14. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells.
Sheikh MS; Shao ZM; Hussain A; Clemmons DR; Chen JC; Roberts CT; LeRoith D; Fontana JA
J Cell Physiol; 1993 Jun; 155(3):556-67. PubMed ID: 7684042
[TBL] [Abstract][Full Text] [Related]
15. Two E-selectin ligands, BST-2 and LGALS3BP, predict metastasis and poor survival of ER-negative breast cancer.
Woodman N; Pinder SE; Tajadura V; Le Bourhis X; Gillett C; Delannoy P; Burchell JM; Julien S
Int J Oncol; 2016 Jul; 49(1):265-75. PubMed ID: 27176937
[TBL] [Abstract][Full Text] [Related]
16. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
[TBL] [Abstract][Full Text] [Related]
17. CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systems.
Liverani C; Mercatali L; Spadazzi C; La Manna F; De Vita A; Riva N; Calpona S; Ricci M; Bongiovanni A; Gunelli E; Zanoni M; Fabbri F; Zoli W; Amadori D; Ibrahim T
Bone; 2014 Sep; 66():214-22. PubMed ID: 24956020
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody.
Traini S; Piccolo E; Tinari N; Rossi C; La Sorda R; Spinella F; Bagnato A; Lattanzio R; D'Egidio M; Di Risio A; Tomao F; Grassadonia A; Piantelli M; Natoli C; Iacobelli S
Mol Cancer Ther; 2014 Apr; 13(4):916-25. PubMed ID: 24552775
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell-specific ICAM-3-grabbing nonintegrin expression on M2-polarized and tumor-associated macrophages is macrophage-CSF dependent and enhanced by tumor-derived IL-6 and IL-10.
Domínguez-Soto A; Sierra-Filardi E; Puig-Kröger A; Pérez-Maceda B; Gómez-Aguado F; Corcuera MT; Sánchez-Mateos P; Corbí AL
J Immunol; 2011 Feb; 186(4):2192-200. PubMed ID: 21239715
[TBL] [Abstract][Full Text] [Related]
20. Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target.
Capone E; Iacobelli S; Sala G
J Transl Med; 2021 Sep; 19(1):405. PubMed ID: 34565385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
